Skip to main navigation

IR Navigation

Overview
News & Events
Governance
Financial Information
- SEC Filings
- Annual Report & Proxy Materials
Stock Information
Investor Resources

« Solidbio.com

Stock Information

Stock Quote & Chart

NASDAQ SLDB

Apr 15, 2022 4:13 AM EDT

Change

Volume

Today's Open

Previous Close

Today's High

Today's Low

52 Week High

52 Week Low

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Footer Links

Contact Us
Privacy
Terms and Conditions

© 2022 Solid Biosciences Inc. All rights reserved.

Solid Biosciences Inc., is a Cambridge, MA-based life science company committed to solving Duchenne muscular dystrophy and improving the lives of patients. Solid is currently developing gene therapies, disease modifying therapies and assistive devices, all targeting the many facets of the disease.

The characterization of the discovery and development efforts on this website, as well as the expectations associated with them, are reflective of the current state of development and may change as the Company progresses.